Zobrazeno 1 - 10
of 130 426
pro vyhledávání: '"Leukemia, myeloid"'
Autor:
Kim SY; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: ksuny55@gmail.com., Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Kim J; Department of Laboratory Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Kwon GC; Department of Laboratory Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
Publikováno v:
Annals of diagnostic pathology [Ann Diagn Pathol] 2024 Aug; Vol. 71, pp. 152317. Date of Electronic Publication: 2024 Apr 18.
Autor:
Niibori-Nambu A; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Wang CQ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Chin DWL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Chooi JY; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Hosoi H; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan., Sonoki T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan., Tham CY; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Nah GSS; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Cirovic B; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Tan DQ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Takizawa H; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan., Sashida G; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan., Goh Y; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Tng J; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Fam WN; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Fullwood MJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Suda T; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan; Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Yang H; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Tergaonkar V; Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore., Taniuchi I; Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Li S; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore., Chng WJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; National University Cancer Institute, Singapore; National University Health System, Singapore. Electronic address: weejoo.chng@nus.edu.sg., Osato M; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of General Internal Medicine, Kumamoto Kenhoku Hospital, Kumamoto, Japan. Electronic address: motokuma@kumamoto-u.ac.jp.
Publikováno v:
Gene [Gene] 2024 Nov 30; Vol. 928, pp. 148761. Date of Electronic Publication: 2024 Jul 11.
Autor:
Wang ZK; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Zhang ZW; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Lyu ZS; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Xing T; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China., Liang M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Shen MZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Li CY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Zhang XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Chen DD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Wang YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Hu LJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China., Kong Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China. Electronic address: yuankong@bjmu.edu.cn., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China; State Key Laboratory of Natural and Biomimetic Drugs, Beijing, China. Electronic address: huangxiaojun@bjmu.edu.cn.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Nov 28; Vol. 605, pp. 217290. Date of Electronic Publication: 2024 Oct 11.
Autor:
Gao J; Department of Hematology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China., Yan X; Department of Hematology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China., Fan D; Department of Hematology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China., Li Y; Department of Hematology, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Publikováno v:
PeerJ [PeerJ] 2024 Nov 21; Vol. 12, pp. e18521. Date of Electronic Publication: 2024 Nov 21 (Print Publication: 2024).
Autor:
Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Appelbaum FR; Division of Hematology and Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA., Craddock C; University of Warwick Trials Unit, Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Dombret H; Department of Hematology, Saint-Louis Institute for Research, Université Paris Cité, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université de Paris Cité, Paris, France., Godley LA; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA., Larson RA; Department of Medicine and Comprehensive Cancer Center, The University of Chicago, Chicago, IL., Levine RL; Department of Medicine, Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Niederwieser D; Division of Hematology and Medical Oncology, University of Leipzig, Leipzig, Germany., Ossenkoppele G; Department of Hematology, Amsterdam University Medical Center, Location Vrije Universiteit Medical Center, Amsterdam, The Netherlands., Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany., Sierra J; Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Stein EM; Department of Medicine, Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Tallman MS; Department of Medicine, Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Wang J; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Wierzbowska A; Department of Hematology, Medical University of Lodz, Lodz, Poland., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia., Löwenberg B; Department of Hematology, Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2024 Nov 21; Vol. 144 (21), pp. 2169-2173.
Autor:
Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Pratz KW; Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Wei AH; Department of Clinical Haematology, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and The University of Melbourne, Melbourne, Australia., Jonas BA; Division of Malignant Hematology/Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA., Pullarkat VA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA., Thirman MJ; Department of Medicine, Section of Hematology and Oncology, University of Chicago Medicine, Chicago, IL., Récher C; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Schuh AC; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada., Babu S; Division of Clinical Research, Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN., Li X; AbbVie Inc, North Chicago, IL., Ku G; Genentech Inc, South San Francisco, CA., Liu Z; AbbVie Inc, North Chicago, IL., Sun Y; AbbVie Inc, North Chicago, IL., Potluri J; AbbVie Inc, North Chicago, IL., Dail M; Genentech Inc, South San Francisco, CA., Chyla B; AbbVie Inc, North Chicago, IL., Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, CO.
Publikováno v:
Blood [Blood] 2024 Nov 21; Vol. 144 (21), pp. 2211-2222.
Autor:
Shahzad M; Division of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL, USA., Amin MK; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah MV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hiwase D; Department of Hematology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia., Arber DA; Department of Pathology, University of Chicago, Chicago, IL, USA., Kharfan-Dabaja MA; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Badar T; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA. badar.talha@mayo.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Nov 19; Vol. 14 (1), pp. 202. Date of Electronic Publication: 2024 Nov 19.
Autor:
Rubino V; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Hüppi M; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland., Höpner S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland., Tortola L; Institute for Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland., Schnüriger N; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Legenne H; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Taylor L; Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland., Voggensperger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland., Keller I; Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland., Bruggman R; Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland., Kronig MN; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Kopf M; Institute for Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland., Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland., Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. Electronic address: carsten.riether@insel.ch.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Nov 19; Vol. 5 (11), pp. 101826. Date of Electronic Publication: 2024 Nov 12.
Autor:
Nadiminti KVG; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI, 53705-2281, USA. knadimin@medicine.wisc.edu., Sahasrabudhe KD; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI, 53705-2281, USA., Liu H; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI, 53705-2281, USA.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Nov 18; Vol. 17 (1), pp. 113. Date of Electronic Publication: 2024 Nov 18.
Autor:
Urrutia S; Division of Oncology, Washington University in St Louis, St Louis, 200233, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Dinardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA. ksasaki1@mdanderson.org.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Nov 15; Vol. 17 (1), pp. 112. Date of Electronic Publication: 2024 Nov 15.